DE Reece

1.4k total citations
25 papers, 998 citations indexed

About

DE Reece is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, DE Reece has authored 25 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 11 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in DE Reece's work include Lymphoma Diagnosis and Treatment (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Lung Cancer Treatments and Mutations (6 papers). DE Reece is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Lung Cancer Treatments and Mutations (6 papers). DE Reece collaborates with scholars based in Canada, United States and Italy. DE Reece's co-authors include JD Shepherd, Klingemann Hg, MJ Barnett, GL Phillips, SH Nantel, HJ Sutherland, JJ Spinelli, Hans-Georg Klingemann, Séamus O’Reilly and AP Grigg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Cancer.

In The Last Decade

DE Reece

25 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
DE Reece Canada	14	450	423	343	251	201	25	998
JD Shepherd Canada	18	407 0.9×	560 1.3×	394 1.1×	228 0.9×	168 0.8×	24	1.1k
John Amess United Kingdom	12	619 1.4×	372 0.9×	445 1.3×	358 1.4×	124 0.6×	16	1.3k
Michel Blanc France	14	757 1.7×	150 0.4×	386 1.1×	371 1.5×	427 2.1×	35	1.0k
Silvia Franceschetti Italy	17	751 1.7×	112 0.3×	366 1.1×	422 1.7×	245 1.2×	47	1.3k
Jean Pierre Marolleau France	17	397 0.9×	263 0.6×	324 0.9×	191 0.8×	79 0.4×	53	977
C.F. LeMaistre United States	15	230 0.5×	451 1.1×	367 1.1×	176 0.7×	105 0.5×	27	829
Jean-Philippe Laporte France	12	492 1.1×	486 1.1×	431 1.3×	296 1.2×	155 0.8×	13	1.0k
J.E. Gottenberg France	14	265 0.6×	129 0.3×	151 0.4×	177 0.7×	67 0.3×	34	1.4k
John Apostolidis Greece	13	586 1.3×	223 0.5×	473 1.4×	214 0.9×	122 0.6×	34	810
Ruth Langholm Norway	15	251 0.6×	336 0.8×	193 0.6×	246 1.0×	49 0.2×	30	799

Countries citing papers authored by DE Reece

Since Specialization

Citations

This map shows the geographic impact of DE Reece's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DE Reece with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DE Reece more than expected).

Fields of papers citing papers by DE Reece

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DE Reece. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DE Reece. The network helps show where DE Reece may publish in the future.

Co-authorship network of co-authors of DE Reece

This figure shows the co-authorship network connecting the top 25 collaborators of DE Reece. A scholar is included among the top collaborators of DE Reece based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DE Reece. DE Reece is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Reece, DE, Ute Hegenbart, Vaishali Sanchorawala, et al.. (2010). Weekly and twice-weekly bortezomib in AL amyloidosis: Results of a phase II study.. Journal of Clinical Oncology. 28(15_suppl). 8023–8023. 1 indexed citations

2.

Reeder, Craig B., M. Q. Lacy, DE Reece, et al.. (2010). A comparison of lenalidomide/dexamethasone (RD) versus cyclophosphamide/lenalidomide/dexamethasone (CRD) versus cyclophosphamide/bortezomib/dexamethasone (CyborD) in newly diagnosed multiple myeloma (MM).. Journal of Clinical Oncology. 28(15_suppl). 8131–8131. 4 indexed citations

3.

Reece, DE, Vaishali Sanchorawala, Ute Hegenbart, et al.. (2007). Phase I/II study of bortezomib (B) in patients with systemic AL-amyloidosis (AL). Journal of Clinical Oncology. 25(18_suppl). 8050–8050. 6 indexed citations

4.

Reece, DE, Neal Flomenberg, G. L. Phillips, et al.. (2006). Update of melphalan 280 mg/m²plus amifostine cytoprotection before autologous stem cell transplantation as part of initial therapy in multiple myeloma patients. Journal of Clinical Oncology. 24(18_suppl). 7608–7608. 4 indexed citations

5.

Toze, Cynthia L., JD Shepherd, R. D. Gascoyne, et al.. (2000). Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia. Bone Marrow Transplantation. 25(6). 605–612. 56 indexed citations

6.

Reece, DE, KA Foon, Malaya Bhattacharya‐Chatterjee, et al.. (2000). Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer. Bone Marrow Transplantation. 26(7). 729–735. 15 indexed citations

7.

Toze, Cynthia L., John D. Shepherd, Joseph M. Connors, et al.. (2000). Allografting for indolent lymphoid neoplasms. Annals of Oncology. 11. S59–S61. 7 indexed citations

8.

Reece, DE, Moumita Chatterjee, Kent Holland, et al.. (1999). Anti-idiotype (anti-ID) vaccination plus intensive therapy (IT) and autologous stem cell transplantation (ASCT) for patients (PTS) with metastatic breast cancer (MBC). European Journal of Cancer. 35. S353–S353. 1 indexed citations

9.

Reece, DE, MJ Barnett, JD Shepherd, et al.. (1995). High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy. Blood. 86(2). 451–456. 100 indexed citations

10.

Reece, DE, JJ Spinelli, MJ Barnett, et al.. (1994). Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]. Blood. 83(5). 1193–1199. 163 indexed citations

11.

Murray, Nevin, DE Reece, Klingemann Hg, et al.. (1993). High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours. British Journal of Cancer. 68(3). 594–598. 22 indexed citations

12.

Cuthbert, R, G. L. Phillips, M. J. Barnett, et al.. (1992). Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy.. PubMed. 10(5). 451–5. 30 indexed citations

13.

Phillips, G. L., DE Reece, & J M Connors. (1992). Bone marrow transplantation in Hodgkin's disease.. PubMed. 10 Suppl 1. 64–6. 2 indexed citations

14.

Hg, Klingemann, AP Grigg, MJ Barnett, et al.. (1991). Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected] [published erratum appears in Blood 1992 Jun 15;79(12):3397]. Blood. 78(12). 3306–3311. 55 indexed citations

15.

Lohri, Andreas, et al.. (1991). Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988. Blood. 77(10). 2292–2298. 104 indexed citations

16.

Reece, DE, JD Shepherd, Katerina Dorovini‐Zis, et al.. (1991). Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin.. PubMed. 8(5). 393–401. 145 indexed citations

17.

Lohri, Andreas, et al.. (1991). Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988. Blood. 77(10). 2292–2298. 8 indexed citations

18.

Hg, Klingemann, AP Grigg, MJ Barnett, et al.. (1991). Treatment with recombinant interferon (alpha-2b) early after bone marrow transplantation in patients at high risk for relapse [corrected] [published erratum appears in Blood 1992 Jun 15;79(12):3397]. Blood. 78(12). 3306–3311. 67 indexed citations

19.

Phillips, GL, DE Reece, JD Shepherd, et al.. (1991). High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults. Blood. 77(7). 1429–1435. 66 indexed citations

20.

Turhan, Ali G., R. Keith Humphries, CJ Eaves, et al.. (1990). Detection of breakpoint cluster region- negative and nonclonal hematopoiesis in vitro and in vivo after transplantation of cells selected in cultures of chronic myeloid leukemia marrow. Blood. 76(11). 2404–2410. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact